Pradžia › Demencija › Masčusetsas
Demencija klinikiniai tyrimai Masčusetsas
17 tyrimai dėl Demencija ieško dalyvių vietose Masčusetsas.
Miestai Masčusetsas
Oficialus tyrimo tekstas (anglų kalba)
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- Local Institution - 0080, Watertown
Renkami dalyviai3 fazė
Amžius nuo 60 iki 85 · Visoms lytims · Atnaujinta 2026-09-17 · NCT06976203Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type
- Vitalix, Worcester
Renkami dalyviai2 fazė
Visi amžiai · Visoms lytims · Atnaujinta 2026-09-16 · NCT06052254The BRAIN App (Phase 2 SBIR)
- Hopeful Aging, Winchester
Renkami dalyviai
Amžius 65 ir vyresni · Visoms lytims · Atnaujinta 2026-09-15 · NCT06298474Making Connections Thru Music
- Hopeful Aging, Winchester
- The Hearthstone Institute, LLC, Winchester
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius nuo 18 iki 103 · Visoms lytims · Atnaujinta 2026-09-15 · NCT06079216Sleep and Circadian Rhythm Biomarkers of Postoperative Delirium
- Massachusetts General Hospital, Boston
Renkami dalyviaiStebimasis tyrimas
Amžius 70 ir vyresni · Visoms lytims · Atnaujinta 2026-09-14 · NCT06052397Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
- VA Boston Healthcare System, Boston
Renkami dalyviai4 fazėLaukiami sveiki savanoriai
Amžius 75 ir vyresni · Visoms lytims · Atnaujinta 2026-09-01 · NCT04262206A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
- Massachusetts General Hospital (MGH), Charlestown
Renkami dalyviai1 fazė
Amžius nuo 50 iki 85 · Visoms lytims · Atnaujinta 2026-08-24 · NCT06297590A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Boston Center for Memory, Newton
Renkami dalyviai3 fazė
Amžius nuo 60 iki 85 · Visoms lytims · Atnaujinta 2026-08-20 · NCT06976216Home-Based Brain Stimulation for Motoric Cognitive Risk Syndrome
- Hebrew Rehabilitation Center, Roslindale
Renkami dalyviai
Amžius nuo 65 iki 90 · Visoms lytims · Atnaujinta 2026-07-16 · NCT06821568A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Boston Center for Memory, Newton
- MedVadis Research Corporation, Waltham
Renkami dalyviai3 fazė
Amžius 55 ir vyresni · Visoms lytims · Atnaujinta 2026-07-07 · NCT07602582A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
- ActivMed Practices and Research, Methuen
Renkami dalyviai2 fazė
Amžius nuo 50 iki 85 · Visoms lytims · Atnaujinta 2026-06-26 · NCT07094516Trial-Ready Cohort-Down Syndrome (TRC-DS)
- Massachusetts General Hospital, Co-Enrolling through ABC-DS Only, Boston
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 25 iki 55 · Visoms lytims · Atnaujinta 2026-05-18 · NCT04165109Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease
- Center for Alzheimer Research and Treatment, Brigham and Women's Hospital, Boston
Renkami dalyviai2 fazė
Amžius nuo 60 iki 85 · Visoms lytims · Atnaujinta 2026-02-12 · NCT06489548Non-invasive Brain Stimulation for Cognitive and Motor Dysfunction in Dementia
- Hinda and Arthur Marcus Institute for Aging Research, Boston
Renkami dalyviai
Amžius 55 ir vyresni · Visoms lytims · Atnaujinta 2026-01-12 · NCT05661084Trial to Reduce Antimicrobial Use in Nursing Home Residents With Alzheimer's Disease and Other Dementias 2.0
- Hebrew SeniorLife, Boston
Renkami dalyviai
Amžius nuo 60 iki 106 · Visoms lytims · Atnaujinta 2026-01-06 · NCT05950607Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside
- McLean Hospital, Belmont
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 18 iki 89 · Visoms lytims · Atnaujinta 2025-11-06 · NCT05245903Assess Fibrin in Brains With AD/ADRD
- Massachusetts General Hospital, Boston
Renkami dalyviai1/2 fazėLaukiami sveiki savanoriai
Amžius nuo 55 iki 90 · Visoms lytims · Atnaujinta 2025-10-30 · NCT05336695Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.